Conference abstractPublished 20 Jun 2016
Non-transpeptidase binding lactams active against Mycobacterium tuberculosis
American University, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
We have designed Non-transpeptidase binding lactams active against Mycobacterium tuberculosis, synthesized and tested a novel class of non-transpeptidase, β-lactamase resistant monocyclic β-lactams that carry an arylthio group at C4; these thio ethers exhibit inhibitory and cidal highly active against the serine beta-lactamase producing Mycobacterium tuberculosis H37Rv (Mtb). Some of the compounds have demonstrated minimal inhibitory concentration (MIC) as low as 6.25 µg/ml in 7H9 and 0.19 µg/ml in GAST. Preliminary investigations indicate that these compounds are cidal to both replicating and non-replicating persistent Mtb. These compounds are promising candidates for lead optimization and target identification studies which are currently underway.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectInfectious Diseases
- SubjectPulmonology & Respiratory
- BylineArticles whose byline prints “Monika I. Konaklieva”
